Lacosamide Injection
Product Images NDC 43598-087

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Lacosamide (NDC 43598-087). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dr. Reddy's Laboratories Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton (Carton)

The label is for Lacosamide Injection, USP, 200 mg/20 mL (10 mg/mL) intravenous injection by Dr. Reddy's Laboratories Inc. It includes details for 10 single-dose vials of 20 mL each. The label highlights dosage strength, route, usage instructions, inactive ingredients, storage conditions, and labeling information including the NDC 43598-087-58 and distributor address in Princeton, NJ.*

FDA Label Image

Figure1 (Figure1)

A bar chart showing median percent change from baseline in seizure reduction across three studies comparing placebo and Lacosamide at various doses (200, 400, 600 mg/day). The graph illustrates higher seizure reduction percentages in Lacosamide groups compared to placebo, with statistical significance indicated. Sample sizes for each group are noted below the bars.*

FDA Label Image

Figure2 (Figure2)

A cumulative response rate graph showing percent of patients on the x-axis and responder rate (equal to or greater) on the y-axis. The graph compares placebo and three dosage groups of lacosamide injection (200 mg/day, 400 mg/day, and 600 mg/day) across patient samples, illustrating improvement and worsening response rates.*

FDA Label Image

Figure3 (Figure3)

A Kaplan-Meier survival curve comparing the proportion of patients over time (in days) between Lacosamide and placebo groups. The graph shows higher survival proportion for Lacosamide patients versus placebo. The chart includes number-at-risk tables and statistical data such as hazard ratio, confidence intervals, and p-value.*

FDA Label Image

Structure (Structure)

Chemical structure of Lacosamide, depicting its molecular arrangement including acetyl, amide, methoxy, and phenyl functional groups as part of the compound.*

FDA Label Image

Vial (Vial)

Label for Lacosamide Injection USP 200 mg/20 mL (10 mg/mL) single-dose vial, for intravenous use only. The label includes storage instructions, dosage directions to see package insert, and a barcode. It is distributed by Dr. Reddy's Laboratories Inc. and is marked Rx only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.